Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative IBRX - ImmunityBio, Inc.
130 M
LAST VALUE
-2.11%
2 YEAR CAGR
29.59%
5 YEAR CAGR
48.90%
10 YEAR CAGR